NCT04488263
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: Neuroendocrine tumor (NET)
Recruitment Status: Recruiting

Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 3 Years and older (Child, Adult, Older Adult))
Location of Metastases: 
Additional Notes: Patient must have also been enrolled in the clinical trial NCT03739827
Exclusions: 
https://ClinicalTrials.gov/show/NCT04488263